Alessandro Marchetti

Alessandro Marchetti

Auto-generated profile, based on publicly available information

Alessandro Marchetti

University Campus Bio-Medico of Rome, Via Alvaro del Portillo 21, Rome, 00128, RM, Italy

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in Nuclear Physics B
Verified
Journal Article
Open access
MBMassimo Bianchi
Massimo Bianchi
AMAlessandro Marchetti
Alessandro Marchetti
Within the program of holographic renormalization, we discuss the computation of three-point correlation functions along RG flows. We illustrate the procedure in two simple cases. In an RG flow to the Coulomb branch of N =4 SYM theory we derive a compact and finite expression for the three-point function of lowest CPOs dual to inert scalars. In the GPPZ flow, that captures some features of N =1 SYM theory, we identify two new logarithmically divergent counterterms and compute the three-point function with insertion of two inert scalars and one active scalar that mixes with the stress tensor. By amputating the external legs at the mass poles we extract the finite and scheme independent trilinear couplings of the corresponding superglueballs. Finally we outline the procedure for computing three-point functions with insertions of the stress tensor as well as of (broken) R-symmetry currents.

18 January 2023 in IEEE Access
Verified
Journal Article
Open access
FDFederico D'Antoni
Federico D'Antoni
LPLorenzo Petrosino
Lorenzo Petrosino
AMAlessandro Marchetti
Alessandro Marchetti
LBLuca Bacco
Luca Bacco
SPSilvia Pieralice
Silvia Pieralice
Mario MeroneMario Merone
Mario Merone
Type 1 diabetes mellitus (T1D) is a chronic disease that, if not treated properly, can lead to serious complications. We propose a layered meta-learning approach based on multi-expert systems to predict adverse events in T1D. The base learner is composed of three deep neural networks and exploits only continuous glucose monitoring data as an input feature. Each network specializes in predicting whether the patient is about to experience hypoglycemia, hyperglycemia, or euglycemia. The output of the experts is passed to a meta-learner to provide the final model classification. In addition, we formally introduce a novel parameter, α, to evaluate the advance by which a prediction is performed. We evaluate the proposed approach on both a public and a private dataset and implement it on an edge device to test its feasibility in real life. On average, on the Ohio T1DM dataset, our system was able to predict hypoglycemia events with a time gain of 22.8 minutes, hyperglycemia ones with an advance of 24.0 minutes. Our model not only outperforms presented models in the literature in terms of events predicted with sufficient advance, but also with regard to the number of false positives, achieving on average 0.45 and 0.46 hypo- and hyperglycemic false alarms per day, respectively. Furthermore, the meta-learning approach effectively improves performance in a new cohort of patients by training only the meta-learner with a limited amount of data.We believe our approach would be an essential ally for the patients to control the glycemic fluctuations and adjust their insulin therapy and dietary intakes, enabling them to speed up decision-making and improve personal self-management, resulting in a reduced risk of acute and chronic complications. As our last contribution, we assessed the validity of the approach by exploiting only blood glucose variations as well as in combination with the information of the insulin boluses, the skin temperature, and the galvanic skin response. In general, we have observed that providing other information but CGM leads to slightly lower performances with respect to considering CGM alone.

15 April 2025 in Computers in Biology and Medicine
Verified
Journal Article
Open access
AMAlessandro Marchetti
Alessandro Marchetti
DSDaniele Sasso
Daniele Sasso
FDFederico D'Antoni
Federico D'Antoni
FMFrancesco Morandin
Francesco Morandin
MPMaurizio Parton
Maurizio Parton
Mario MeroneMario Merone
Mario Merone
Managing blood glucose levels in Type 1 Diabetes Mellitus (T1DM) is essential to prevent complications. Traditional insulin delivery methods often require significant patient involvement, limiting automation. Reinforcement Learning (RL)-based controllers offer a promising approach for improving automated insulin administration. We propose a Dual Proximal Policy Optimization (Dual PPO) controller for personalized insulin delivery in a hybrid closed-loop system. The controller optimizes patient-specific insulin bounds through a grid search on pre-trained models to manage both hyperglycemia and hypoglycemia. A safe-control mechanism prevents insulin administration when glucose levels drop below a predefined threshold. The system was evaluated on 10 in silico adult patients using the UVA/Padova simulator, with five-day randomized meal scenarios. The Dual PPO controller significantly improved Time in Range (TIR) (69.30% ±1.61) compared to a single PPO model (61.69% ±1.54). The system effectively reduced severe hyperglycemia while maintaining a low incidence of severe hypoglycemia. Unlike conventional open-loop methods such as Basal-Bolus (BBC) and Proportional-Integral-Derivative (PIDC) controllers, our system requires minimal patient interaction, eliminating the need for carbohydrate estimation. The Dual PPO controller enhances personalized insulin delivery in T1DM, improving glycemic control while reducing patient burden. This approach advances precision medicine in diabetes management, with potential for future real-world applications.

13 November 2025 in Biomedical Signal Processing and Control
Verified
Journal Article
Closed access
AGAlberto Maria Di Giacinto
Alberto Maria Di Giacinto
LPLorenzo Petrosino
Lorenzo Petrosino
FDFederico D'Antoni
Federico D'Antoni
AMAlessandro Marchetti
Alessandro Marchetti
Luca VolleroLuca Vollero
Luca Vollero
Mario MeroneMario Merone
Mario Merone

1 October 2025
Verified
Book Chapter
Closed access
Carlo MettaCarlo Metta
Carlo Metta
MFMarco Fantozzi
Marco Fantozzi
APAndrea Papini
Andrea Papini
GAGianluca Amato
Gianluca Amato
MBMatteo Bergamaschi
Matteo Bergamaschi
FMFrancesco Morandin
Francesco Morandin

9 January 2023 in arXiv
Verified
Preprint
Open access
PDF file
LPLuca Pasqualini
Luca Pasqualini
GAGianluca Amato
Gianluca Amato
MFMarco Fantozzi
Marco Fantozzi
Rosa GiniRosa Gini
Rosa Gini
AMAlessandro Marchetti
Alessandro Marchetti
MPMaurizio Parton
Maurizio Parton
In the last years, the DeepMind algorithm AlphaZero has become the state of the art to efficiently tackle perfect information two-player zero-sum games with a win/lose outcome. However, when the win/lose outcome is decided by a final score difference, AlphaZero may play score-suboptimal moves because all winning final positions are equivalent from the win/lose outcome perspective. This can be an issue, for instance when used for teaching, or when trying to understand whether there is a better move. Moreover, there is the theoretical quest for the perfect game. A naive approach would be training an AlphaZero-like agent to predict score differences instead of win/lose outcomes. Since the game of Go is deterministic, this should as well produce an outcome-optimal play. However, it is a folklore belief that "this does not work". In this paper, we first provide empirical evidence for this belief. We then give a theoretical interpretation of this suboptimality in general perfect information two-player zero-sum game where the complexity of a game like Go is replaced by the randomness of the environment. We show that an outcome-optimal policy has a different preference for uncertainty when it is winning or losing. In particular, when in a losing state, an outcome-optimal agent chooses actions leading to a higher score variance. We then posit that when approximation is involved, a deterministic game behaves like a nondeterministic game, where the score variance is modeled by how uncertain the position is. We validate this hypothesis in AlphaZero-like software with a human expert.